Filter News
Area of Research
- (-) Computational Engineering (1)
- (-) Neutron Science (4)
- Biological Systems (1)
- Biology and Environment (9)
- Clean Energy (33)
- Computational Biology (1)
- Computer Science (5)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (1)
- Isotopes (1)
- Materials (15)
- National Security (9)
- Quantum information Science (1)
- Supercomputing (19)
- Transportation Systems (1)
News Type
News Topics
- (-) Artificial Intelligence (3)
- (-) Biomedical (2)
- Big Data (1)
- Bioenergy (1)
- Biology (2)
- Clean Water (1)
- Computer Science (4)
- Cybersecurity (1)
- Decarbonization (1)
- Energy Storage (5)
- Environment (5)
- Frontier (1)
- Machine Learning (2)
- Materials (3)
- Materials Science (4)
- Microscopy (1)
- National Security (1)
- Neutron Science (28)
- Nuclear Energy (1)
- Physics (3)
- Quantum Science (2)
- Security (1)
- Space Exploration (1)
- Summit (1)
Media Contacts
While studying how bio-inspired materials might inform the design of next-generation computers, scientists at ORNL achieved a first-of-its-kind result that could have big implications for both edge computing and human health.
Oak Ridge National Laboratory researchers are developing a first-of-its-kind artificial intelligence device for neutron scattering called Hyperspectral Computed Tomography, or HyperCT.
A study led by Oak Ridge National Laboratory explored the interface between the Department of Veterans Affairs’ healthcare data system and the data itself to detect the likelihood of errors and designed an auto-surveillance tool
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
As the rise of antibiotic-resistant bacteria known as superbugs threatens public health, Oak Ridge National Laboratory’s Shuo Qian and Veerendra Sharma from the Bhaba Atomic Research Centre in India are using neutron scattering to study how an antibacterial peptide interacts with and fights harmful bacteria.